It has been previously demonstrated that the oncogenes BCL/ABL in chronic myelogenous leukemia [16] and HER3 in breast cancer [17, 18] regulated NKG2D ligands expression via PI3K/AKT signalling. The gene discussed is KLRK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.